Evidence map›Paper›PMID 29572708›Full record

ReviewEndocrine2018

Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives.

Andrea Salzano, Roberta D'Assante, Liam M Heaney, Federica Monaco, Giuseppe Rengo, Pietro Valente, Daniela Pasquali, Eduardo Bossone, Daniele Gianfrilli, Andrea Lenzi and 3 more

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Endocrine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Male Fertility as a Proxy for Health.Journal of clinical medicine · 2024
    Review
  5. The impact of chromosomal sex on cardiometabolic health and disease.Trends in endocrinology and metabolism: TEM · 2023
    Review
  6. Review
  7. Observational
  8. Observational
  9. Observational
  10. Review
  11. In-vivo skeletal muscle mitochondrial function in Klinefelter syndrome.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Nonsurgical Management of Oligozoospermia.The Journal of clinical endocrinology and metabolism · 2020
    Article
  19. High prevalence of cardiometabolic risk features in adolescents with 47,XXY/Klinefelter syndrome.American journal of medical genetics. Part C, Seminars in medical genetics · 2020
    Article
  20. Comprehensive men's health and male infertility.Translational andrology and urology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Andrea SalzanoDepartment of Translational Medical Sciences, Federico II University School of Medicine, Naples, Italy.
Roberta D'AssanteIRCCS S.D.N., Via Gianturco 113, 80143, Naples, Italy.
Liam M HeaneyDepartment of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Glenfield Hospital, Leicester, UK.
Federica MonacoDepartment of Translational Medical Sciences, Federico II University School of Medicine, Naples, Italy.
Giuseppe RengoDepartment of Translational Medical Sciences, Federico II University School of Medicine, Naples, Italy.
Pietro ValenteDepartment of Translational Medical Sciences, Federico II University School of Medicine, Naples, Italy.
Daniela PasqualiDepartment of Neurological, Metabolic, and Geriatric Science, Endocrinology Unit, University of Campania "Luigi Vanvitelli", Caserta, Italy.
Eduardo BossoneDepartment of Cardiology and Cardiac Surgery, University Hospital "Scuola Medica Salernitana", Salerno, Italy.
Daniele GianfrilliDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Andrea LenziDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Antonio CittadiniDepartment of Translational Medical Sciences, Federico II University School of Medicine, Naples, Italy. antonio.cittadini@unina.it.ORCID http://orcid.org/0000-0003-2352-2103
Alberto M MarraIRCCS S.D.N., Via Gianturco 113, 80143, Naples, Italy.
Raffaele NapoliDepartment of Translational Medical Sciences, Federico II University School of Medicine, Naples, Italy.
Federico II University Hospital · ITSapienza University of Rome · ITSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversity of Leicester · GBUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeKlinefelter syndrome (KS), the most frequent chromosomic abnormality in males, is associated with hypergonadotropic hypogonadism and an increased risk of cardiovascular diseases (CVD). The mechanisms involved in increasing risk of cardiovascular morbidity and mortality are not completely understood. This review summarises the current understandings of the complex relationship between KS, metabolic syndrome and cardiovascular risk in order to plan future studies and improve current strategies to reduce mortality in this high-risk population.

methodsWe searched PubMed, Web of Science, and Scopus for manuscripts published prior to November 2017 using key words "Klinefelter syndrome" AND "insulin resistance" OR "metabolic syndrome" OR "diabetes mellitus" OR "cardiovascular disease" OR "testosterone". Manuscripts were collated, studied and carried forward for discussion where appropriate.

resultsInsulin resistance, metabolic syndrome, and type 2 diabetes are more frequently diagnosed in KS than in the general population; however, the contribution of hypogonadism to metabolic derangement is highly controversial. Whether this dangerous combination of risk factors fully explains the CVD burden of KS patients remains unclear. In addition, testosterone replacement therapy only exerts a marginal action on the CVD system.

conclusionSince fat accumulation and distribution seem to play a relevant role in triggering metabolic abnormalities, an early diagnosis and a tailored intervention strategy with drugs aimed at targeting excessive visceral fat deposition appear necessary in patients with KS.

Indexed as

Cardiovascular DiseasesComorbidityDiabetes Mellitus, Type 2Hormone Replacement TherapyHumansHypogonadismInsulin ResistanceKlinefelter SyndromeMaleMetabolic SyndromeMortalityRisk FactorsTestosteroneTestosteroneCardiovascular diseasesDiabetes mellitusInsulin resistanceKlinefelter syndromeMetabolic syndromeTestosterone therapy

Identifiers

PMID29572708
OpenAlexW2793383779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.